Suppr超能文献

禁食对接受胰高血糖素样肽-1激动剂治疗的患者身体活动动机和体重减轻的影响:一项定性研究。

Impact of Fasting on Physical Activity Motivation and Weight Reduction in Patients Administered Glucagon-Like Peptide-1 Agonists: A Qualitative Study.

作者信息

Almaqhawi Abdullah, Alabdulqader Razan Anwar, Alkhteeb Nurah Abdullatef, Alomair Fai Ibrahim, Alhassan Sarra Riyadh, Alnajjar Jawad S

机构信息

Department of Family and Community Medicine, College of Medicine, King Faisal University, Al Hofuf, Saudi Arabia.

College of Medicine, King Faisal University, Al Hofuf, Saudi Arabia.

出版信息

Patient Prefer Adherence. 2025 Jan 1;19:19-28. doi: 10.2147/PPA.S496613. eCollection 2025.

Abstract

PURPOSE

This study aims to investigate the possible impacts of fasting on physical activity and weight loss in adult users of glucagon-like peptide-1 (GLP-1) agonists, specifically semaglutide and tirzepatide, using qualitative methods to gain in-depth insights into participants' experiences and perceptions.

PATIENTS AND METHODS

A qualitative study was conducted at the Polyclinic at King Faisal University, Al-Ahsa, Saudi Arabia, during and after Ramadan in 2024, along with the completion of International Physical Activity Questionnaires (IPAQs). The semi-structured interviews and the IPAQ were used to assess physical activity levels. A thematic narrative and framework analysis were used to analyze the data, and a descriptive analysis was performed on the IPAQ data. All participants provided their informed consent, and ethical approval was acquired. A total of 14 interviews were conducted. Five refined themes and 3 sub-themes were identified. The findings were presented in accordance with the COREQ (consolidated criteria for reporting qualitative research) guidelines.

RESULTS

Ten participants, aged 18-59, were included in the study. Half used semaglutide, four used tirzepatide, and one used both, primarily for blood glucose regulation and weight reduction. The average body mass index (BMI) decreased from 35.246 to 34.155. However, a paired -test showed this change was not statistically significant, suggesting that Ramadan fasting did not significantly impact BMI in participants.

CONCLUSION

The research indicated that the combination of GLP-1 agonists and physical activity influenced weight loss during fasting in Ramadan among the participants. These findings suggest that combining these medications with increased physical activity and fasting can effectively reduce BMI and improve overall health outcomes for individuals managing weight and chronic diseases over an extended duration.

摘要

目的

本研究旨在调查禁食对使用胰高血糖素样肽-1(GLP-1)激动剂的成年使用者身体活动和体重减轻的可能影响,特别是司美格鲁肽和替尔泊肽,采用定性方法深入了解参与者的经历和看法。

患者与方法

2024年斋月期间及之后,在沙特阿拉伯艾哈萨法赫德国王大学综合诊所进行了一项定性研究,并完成了国际身体活动问卷(IPAQ)。采用半结构化访谈和IPAQ评估身体活动水平。使用主题叙事和框架分析对数据进行分析,并对IPAQ数据进行描述性分析。所有参与者均提供了知情同意书,并获得了伦理批准。共进行了14次访谈。确定了五个精炼主题和三个子主题。研究结果按照COREQ(定性研究报告的综合标准)指南进行呈现。

结果

该研究纳入了10名年龄在18 - 59岁之间的参与者。其中一半使用司美格鲁肽,4人使用替尔泊肽,1人同时使用这两种药物,主要用于血糖调节和体重减轻。平均体重指数(BMI)从35.246降至34.155。然而,配对检验显示这种变化在统计学上不显著,表明斋月禁食对参与者的BMI没有显著影响。

结论

研究表明,GLP-1激动剂与身体活动相结合,对斋月禁食期间参与者的体重减轻产生了影响。这些发现表明,将这些药物与增加身体活动和禁食相结合,可以有效降低BMI,并在较长时间内改善管理体重和慢性病个体的整体健康状况。

相似文献

本文引用的文献

5
6
Ramadan fasting: recommendations for patients with cardiovascular disease.斋月禁食:心血管疾病患者的建议。
Heart. 2022 Feb;108(4):258-265. doi: 10.1136/heartjnl-2021-319273. Epub 2021 May 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验